Table 1 Details of studies and datasets used for analyses.
From: Causal influence of muscle weakness on cardiometabolic diseases and osteoporosis
Traits | Samples size | Population | Consortium or cohort study (link URL) | |
|---|---|---|---|---|
Exposure | Muscle weakness | 2,56,523 | European | Meta-analysis of 22 cohorts |
Cardiometabolic diseases | Coronary artery disease | 5,47,261 | European | UK Biobank and CARDIoGRAMplusC4D (https://cvd.hugeamp.org/) |
Heart failure | 9,77,323 | European | UK Biobank (http://www.broadcvdi.org/) | |
Atrial fibrillation | 5,87,446 | Mixed | Meta analysis of more than 50 studies (http://www.broadcvdi.org/) | |
Type 2 diabetes | 8,98,130 | European | DIAGRAM (http://diagram-consortium.org) | |
Osteoporosis | eBMD | 4,26,824 | European | GEFOS (http://www.gefos.org) |
Fracutre | 4,26,824 | European |
